Kite Pharma

Kite is the cell therapy unit of Gilead Sciences, developing and commercializing CAR T-cell therapies for cancer, and has partnered with Cellares in a proof-of-concept evaluation of the Cell Shuttle platform.

Company Facts

• Headquarters: Santa Monica, United States
• Type: mature
• Website: https://www.kitepharma.com
• Industries: Cell Therapy, Biopharmaceuticals, Oncology